Government To Amend Norms For Fixing Prices Of 350 Drugs In 15 Days
New Delhi: Drugs Prices Control Order will be amended in the next 15 days to enable the regulator NPPA to fix prices of about 350 medicines whose market data is not available, Union Minister Ananth Kumar said on Monday.
Addressing the foundation day of the National Pharmaceutical Pricing Authority (NPPA), the Chemicals and Fertiliser Minister said the prices of nearly 900 medicines have been fixed under the Drugs (Prices Control) Order, (DPCO) 2013 -- resulting in a saving of about Rs 5,000 crore to consumers.
The pricing of another 368 new formulations has also been fixed, he added.
"For about 350 medicines which are under the National List of Essential Medicines (NLEM) we are not getting any market data. To bring them under the price control, we need to tweak the DPCO. In next 15 days, we are going to make the amendment to empower the NPPA," Kumar said.
He said the government would not be a "mute spectator" and will regulate the prices of these 350 items as well.Â
The minister further said the NPPA would fix the prices of all the remaining medicines in NLEM in a couple of months.Â
Calling pharma as the 'sunrise industry' which is growing at a rapid pace, Kumar said the size of the Indian pharma industry is likely to cross $50 billion in the next three years from $35 billion in 2015.
He noted that 100 per cent FDI has been allowed in pharma sectors, including brownfield projects.
In order to make medicines available at an affordable price, the minister said the government is targeting to open 3,000 Jan Aushadhi stores across the country. At present, there are over 400 stores.
Expressing concerns over the low consumption of medicines by people living below the poverty line, Kumar said there is a need for the NPPA to intervene and regulate the market to make essential drugs affordable to poor as well as producing and making generic drugs available to them.
Kumar also launched a new mobile app 'Pharma Sahi Daam' that will help customers to know the price of medicines fixed by the NPPA. The minister expects this new initiative to be a huge success.
The minister also pitched for making a separate ministry for the pharma sector. He would also request the Prime Minister to declare August 29, the foundation day of NPPA, as 'Rashtriya Jan Aushadhi Divas'.
Emphasising on making the Indian pharma sector globally competitive, Kumar said the government is developing pharma parks and medical devices parks which will reduce the production cost.
Earlier, NPPA Chairman Bhupendra Singh demanded that the DPCO should be amended to fix prices of those 350 medicines whose market data was not available. "There is a need to have relook in DPCO, 2013. Industry requirement is changing and there are many issues which are not taken care in DPCO".
He said the pharma sector is growing at an average of 15 per cent and has touched nearly $35 billion in 2015.
"There has been growth in this sector along with necessary regulations," he said, adding that there is no contradiction between growth and regulation.
Stating that the pricing method adopted by the NPPA is transparent, Singh invited industry to go for settlement in many pending cases.
Sudhansh Pant, Joint Secretary (Pharma), said the price control mechanism is one of the tols to make medicines affordable.
Pant asked the Health Ministry to allow pharmacist of Jan Aushadhi stores to substitute branded medicines by generic medicines.
He said the department is working on another mobile app that would give generic equivalent of branded medicines.
(This story has not been edited by NDTV staff and is auto-generated from a syndicated feed.)
-
Getting To Work Costs Women More | The Reason Why
It is not just about women paying more than men. It is about women paying much more in cities than in villages.
-
AI Bias In Investing Cannot Be Eliminated, But It Can Be Governed
Framing is a particularly important example as identical financial information presented in terms of gains rather than losses can lead an LLM to reach a different assessment.
-
Joining The Dots | Dark Skies, Steady Diya: Why Hope Holds This Diwali
With war, a weak rupee and foreign outflows weighing on sentiment, policymakers at the NDTV World Summit and market veterans at NDTV Profit Ignite: Diwali Edition offered the same advice: stay invested and filter out the noise.
-
The Curious Case of Equitas Small Finance Bank And A CEO Who Quit For Stock
PN Vasudevan believes persistent investor concerns over a perceived conflict of interest had become a governance overhang on Equitas Small Finance Bank's stock, even as the lender improved profitability and asset quality.
-
Talking Points This Week: AI Cash Burn, A Tiger Comeback And An India That Still Finds Its Own Path
India is not immune to higher oil or tighter global liquidity, yet its earnings base is broader, its domestic policy levers are still available.
-
Foreign Investors Own Half Of HDFC Bank and ICICI Bank. An LTCG Cut Could Matter Most Here
Foreign portfolio investors have US$115 billion parked in HDFC Bank, ICICI Bank. If the government cuts long-term capital gains tax, Jefferies says returning foreign money could land here first.
-
'Never Seen This Level Of Negativity': Sandeep Tandon Says The Next Rally May Be Closer Than You Think
Veteran investor Sandeep Tandon says foreign selling is easing, large-caps are due a comeback and mid-caps are crowded, while he turns positive on gold, power and pharma this Diwali.
-
Indians Stay With Family, Not In Hotels | The Reason Why
India still lacks enough clean, reliable and affordable hotels for budget-conscious travellers.
-
The Economic Imperative: Analysing The Material Driving Force Behind India-Canada Strategic Reset
This economic complementarity is further reinforced by deep institutional investment ties and talent mobility, which form the bedrock of the bilateral framework.
-
Medicine Pricing: Where Must Profit Stop?
India must confront excessive margins, hidden incentives and regulatory gaps that threaten the integrity of medicine.